These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 27257622)

  • 1. No Effect of Subthalamic Deep Brain Stimulation on Intertemporal Decision-Making in Parkinson Patients.
    Seinstra M; Wojtecki L; Storzer L; Schnitzler A; Kalenscher T
    eNeuro; 2016; 3(2):. PubMed ID: 27257622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deep brain stimulation of the subthalamic nucleus and the temporal discounting of primary and secondary rewards.
    Aiello M; Terenzi D; Furlanis G; Catalan M; Manganotti P; Eleopra R; Belgrado E; Rumiati RI
    J Neurol; 2019 May; 266(5):1113-1119. PubMed ID: 30762102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of subthalamic nucleus stimulation and levodopa on decision-making in Parkinson's disease.
    Atkinson-Clement C; Cavazzini É; Zénon A; Witjas T; Fluchère F; Azulay JP; Baunez C; Eusebio A
    Mov Disord; 2019 Mar; 34(3):377-385. PubMed ID: 30681186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of Parkinson's disease and subthalamic deep brain stimulation on reward processing.
    Evens R; Stankevich Y; Dshemuchadse M; Storch A; Wolz M; Reichmann H; Schlaepfer TE; Goschke T; Lueken U
    Neuropsychologia; 2015 Aug; 75():11-9. PubMed ID: 25976111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognition and mood in Parkinson's disease in subthalamic nucleus versus globus pallidus interna deep brain stimulation: the COMPARE trial.
    Okun MS; Fernandez HH; Wu SS; Kirsch-Darrow L; Bowers D; Bova F; Suelter M; Jacobson CE; Wang X; Gordon CW; Zeilman P; Romrell J; Martin P; Ward H; Rodriguez RL; Foote KD
    Ann Neurol; 2009 May; 65(5):586-95. PubMed ID: 19288469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and neuropsychological follow up at 12 months in patients with complicated Parkinson's disease treated with subcutaneous apomorphine infusion or deep brain stimulation of the subthalamic nucleus.
    De Gaspari D; Siri C; Landi A; Cilia R; Bonetti A; Natuzzi F; Morgante L; Mariani CB; Sganzerla E; Pezzoli G; Antonini A
    J Neurol Neurosurg Psychiatry; 2006 Apr; 77(4):450-3. PubMed ID: 16543520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute psychotropic effects of bilateral subthalamic nucleus stimulation and levodopa in Parkinson's disease.
    Funkiewiez A; Ardouin C; Krack P; Fraix V; Van Blercom N; Xie J; Moro E; Benabid AL; Pollak P
    Mov Disord; 2003 May; 18(5):524-30. PubMed ID: 12722166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of deep brain stimulation of the subthalamic nucleus on freezing of gait in Parkinson's disease: a prospective controlled study.
    Vercruysse S; Vandenberghe W; Münks L; Nuttin B; Devos H; Nieuwboer A
    J Neurol Neurosurg Psychiatry; 2014 Aug; 85(8):871-7. PubMed ID: 24396010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subthalamic nucleus stimulation, dopaminergic treatment and impulsivity in Parkinson's disease.
    Fluchère F; Burle B; Vidal F; van den Wildenberg W; Witjas T; Eusebio A; Azulay JP; Hasbroucq T
    Neuropsychologia; 2018 Aug; 117():167-177. PubMed ID: 29458074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sensorimotor subthalamic stimulation restores risk-reward trade-off in Parkinson's disease.
    Irmen F; Horn A; Meder D; Neumann WJ; Plettig P; Schneider GH; Siebner HR; Kühn AA
    Mov Disord; 2019 Mar; 34(3):366-376. PubMed ID: 30485537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Meta-analysis comparing deep brain stimulation of the globus pallidus and subthalamic nucleus to treat advanced Parkinson disease.
    Liu Y; Li W; Tan C; Liu X; Wang X; Gui Y; Qin L; Deng F; Hu C; Chen L
    J Neurosurg; 2014 Sep; 121(3):709-18. PubMed ID: 24905564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subthalamic Nucleus Deep Brain Stimulation Modulate Catecholamine Levels with Significant Relations to Clinical Outcome after Surgery in Patients with Parkinson's Disease.
    Yamamoto T; Uchiyama T; Higuchi Y; Asahina M; Hirano S; Yamanaka Y; Kuwabara S
    PLoS One; 2015; 10(9):e0138462. PubMed ID: 26394059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of deep brain stimulation of the subthalamic nucleus on perceptual decision making.
    Zaehle T; Wagenbreth C; Voges J; Heinze HJ; Galazky I
    Neuroscience; 2017 Feb; 343():140-146. PubMed ID: 27956065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deep brain stimulation improves survival in severe Parkinson's disease.
    Ngoga D; Mitchell R; Kausar J; Hodson J; Harries A; Pall H
    J Neurol Neurosurg Psychiatry; 2014 Jan; 85(1):17-22. PubMed ID: 23843542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain connectivity changes when comparing effects of subthalamic deep brain stimulation with levodopa treatment in Parkinson's disease.
    Mueller K; Jech R; Růžička F; Holiga Š; Ballarini T; Bezdicek O; Möller HE; Vymazal J; Růžička E; Schroeter ML; Urgošík D
    Neuroimage Clin; 2018; 19():1025-1035. PubMed ID: 30035027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cognitive and psychiatric outcome 3 years after globus pallidus pars interna or subthalamic nucleus deep brain stimulation for Parkinson's disease.
    Boel JA; Odekerken VJ; Schmand BA; Geurtsen GJ; Cath DC; Figee M; van den Munckhof P; de Haan RJ; Schuurman PR; de Bie RM;
    Parkinsonism Relat Disord; 2016 Dec; 33():90-95. PubMed ID: 27688200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decision-making under risk is improved by both dopaminergic medication and subthalamic stimulation in Parkinson's disease.
    Boller JK; Barbe MT; Pauls KA; Reck C; Brand M; Maier F; Fink GR; Timmermann L; Kalbe E
    Exp Neurol; 2014 Apr; 254():70-7. PubMed ID: 24444545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subthalamic stimulation and levodopa modulate cortical reactivity in Parkinson's patients.
    Casula EP; Stampanoni Bassi M; Pellicciari MC; Ponzo V; Veniero D; Peppe A; Brusa L; Stanzione P; Caltagirone C; Stefani A; Koch G
    Parkinsonism Relat Disord; 2017 Jan; 34():31-37. PubMed ID: 27771287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential effects of levodopa and subthalamic nucleus deep brain stimulation on bradykinesia in Parkinson's disease.
    Timmermann L; Braun M; Groiss S; Wojtecki L; Ostrowski S; Krause H; Pollok B; Südmeyer M; Ploner M; Gross J; Maarouf M; Voges J; Sturm V; Schnitzler A
    Mov Disord; 2008 Jan; 23(2):218-27. PubMed ID: 18044706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eight-year follow-up outcome of subthalamic deep brain stimulation for Parkinson's disease: Maintenance of therapeutic efficacy with a relatively low levodopa dosage and stimulation intensity.
    Jiang L; Chen W; Guo Q; Yang C; Gu J; Xian W; Liu Y; Zheng Y; Ye J; Xu S; Hu Y; Wu L; Chen J; Qian H; Fu X; Liu J; Chen L
    CNS Neurosci Ther; 2021 Nov; 27(11):1366-1373. PubMed ID: 34350691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.